Immune microenvironment, homologous recombination deficiency, and therapeutic response to neoadjuvant chemotherapy in triple-negative breast cancer: Japan Breast Cancer Research Group (JBCRG)22 TR.
- DOI
- 10.1186/s12916-022-02332-1
- Published
- 2022 Apr 25
- Container
- BMC medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s12916-022-02332-1,
title = {Immune microenvironment, homologous recombination deficiency, and therapeutic response to neoadjuvant chemotherapy in triple-negative breast cancer: Japan Breast Cancer Research Group (JBCRG)22 TR.},
author = {Ueno T and Kitano S and Masuda N and Ikarashi D and Yamashita M and Chiba T and Kadoya T and Bando H and Yamanaka T and Ohtani S and Nagai S and Nakayama T and Takahashi M and Saji S and Aogi K and Velaga R and Kawaguchi K and Morita S and Haga H and Ohno S and Toi M},
year = {2022},
journal = {BMC medicine},
doi = {10.1186/s12916-022-02332-1},
url = {https://doi.org/10.1186/s12916-022-02332-1}
}RIS
TY - JOUR TI - Immune microenvironment, homologous recombination deficiency, and therapeutic response to neoadjuvant chemotherapy in triple-negative breast cancer: Japan Breast Cancer Research Group (JBCRG)22 TR. AU - Ueno T AU - Kitano S AU - Masuda N AU - Ikarashi D AU - Yamashita M AU - Chiba T AU - Kadoya T AU - Bando H AU - Yamanaka T AU - Ohtani S AU - Nagai S AU - Nakayama T AU - Takahashi M AU - Saji S AU - Aogi K AU - Velaga R AU - Kawaguchi K AU - Morita S AU - Haga H AU - Ohno S AU - Toi M PY - 2022 JO - BMC medicine DO - 10.1186/s12916-022-02332-1 UR - https://doi.org/10.1186/s12916-022-02332-1 ER -
APA
T, U., S, K., N, M., D, I., M, Y., T, C., T, K., H, B., T, Y., S, O., S, N., T, N., M, T., S, S., K, A., R, V., K, K., S, M., H, H., S, O., & M, T. (2022). Immune microenvironment, homologous recombination deficiency, and therapeutic response to neoadjuvant chemotherapy in triple-negative breast cancer: Japan Breast Cancer Research Group (JBCRG)22 TR.. BMC medicine. https://doi.org/10.1186/s12916-022-02332-1
Source records
- pubmed · retrieved 2026-09-26T17:16:33.399Z